Literature DB >> 25573292

Expression of interleukin-6 is associated with epithelial-mesenchymal transition and survival rates in gallbladder cancer.

Mingdi Zhang1, Wei Gong1, Yong Zhang1, Yong Yang1, Di Zhou1, Mingzhe Weng1, Yiyu Qin1, Alex Jiang2, Fei Ma3, Zhiwei Quan1.   

Abstract

The present study aimed to investigate the expression of interleukin‑6 (IL‑6) in gallbladder cancer (GBC) tissues and its correlation with survival rate. The association between IL‑6 and epithelial‑mesenchymal transition (EMT)‑associated markers was also examined. Using immunohistochemistry, reverse transcription quantitative polymerase chain reaction (RT‑qPCR) and western blot analysis, the protein and mRNA expression levels of IL‑6, Twist, E‑cadherin and Vimentin in 20 GBC tissues were analyzed. The IL‑6, Twist and Vimentin proteins were overexpressed in 40, 20 and 70% of the human GBC samples, respectively. The protein expression of E‑cadherin was higher in only 5% of the GBC samples. These differences were significant (P<0.05). Western blot analysis also revealed overexpression of IL‑6, Twist and Vimentin and underexpression of E‑cadherin in the GBC samples with poor differentiation, local invasion and a higher tumor‑node‑metastasis (TNM) stage (P<0.05). Higher mRNA expression levels of IL‑6, Twist and Vimentin and a reduced expression level of E‑cadherin were also demonstrated in the GBC tissues (P<0.05). The degree of differentiation, local invasion, lymph node metastasis and clinical stage were significantly associated with the mRNA expression levels of IL‑6, Twist and E‑cadherin. The increased expression levels of IL‑6 and Twist and the reduced expression of E‑cadherin correlated with shorter median survival rates (P<0.05). Line regression results revealed correlation among the mRNA expression levels of IL‑6, Twist, E‑cadherin and Vimentin. To the best of our knowledge, the present study is the first to demonstrate that IL‑6 is associated with EMT‑associated markers, tumor differentiation, local invasion, TNM stage and survival rates in GBC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25573292     DOI: 10.3892/mmr.2014.3143

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expression.

Authors:  Sherif A Ibrahim; Eslam A El-Ghonaimy; Hebatallah Hassan; Noha Mahana; Mahmoud Abdelbaky Mahmoud; Tahani El-Mamlouk; Mohamed El-Shinawi; Mona M Mohamed
Journal:  J Adv Res       Date:  2016-06-30       Impact factor: 10.479

Review 2.  Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks.

Authors:  Sunwang Xu; Ming Zhan; Jian Wang
Journal:  Cell Death Discov       Date:  2017-11-27

Review 3.  Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.

Authors:  Aarti Sharma; Kiran Lata Sharma; Annapurna Gupta; Alka Yadav; Ashok Kumar
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

4.  Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells.

Authors:  Xuan Sun; Jie Zhang; Zhiyong Wang; Wei Ji; Ran Tian; Fei Zhang; Ruifang Niu
Journal:  Int J Mol Sci       Date:  2017-02-13       Impact factor: 5.923

5.  Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer.

Authors:  Sarah S Jackson; Vanessa Van De Wyngard; Ruth M Pfeiffer; Paz Cook; Allan Hildesheim; Ligia A Pinto; Sharon H Jackson; Kelvin Choi; Ricardo A Verdugo; Mara Cuevas; Cristian Yáñez; Eduardo Tobar-Calfucoy; Rocío Retamales-Ortega; Juan Carlos Araya; Catterina Ferreccio; Jill Koshiol
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.996

6.  Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis.

Authors:  Qiang Fu; Yuan Chang; Huimin An; Hangcheng Fu; Yu Zhu; Le Xu; Weijuan Zhang; Jiejie Xu
Journal:  Br J Cancer       Date:  2015-11-10       Impact factor: 7.640

7.  Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer.

Authors:  Zhiwei Liu; Troy J Kemp; Yu-Tang Gao; Amanda Corbel; Emma E McGee; Juan Carlos Roa; Bingsheng Wang; Juan Carlos Araya; Ming-Chang Shen; Asif Rashid; Ann W Hsing; Allan Hildesheim; Catterina Ferreccio; Ruth M Pfeiffer; Ligia A Pinto; Jill Koshiol
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.